Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $299K | Hold |
21,823
| – | – | 0.07% | 59 |
|
|
2025
Q1 | $241K | Hold |
21,823
| – | – | 0.06% | 63 |
|
|
2024
Q4 | $232K | Hold |
21,823
| – | – | 0.06% | 59 |
|
|
2024
Q3 | $277K | Hold |
21,823
| – | – | 0.07% | 58 |
|
|
2024
Q2 | $366K | Hold |
21,823
| – | – | 0.1% | 57 |
|
|
2024
Q1 | $327K | Hold |
21,823
| – | – | 0.09% | 59 |
|
|
2023
Q4 | $327K | Hold |
21,823
| – | – | 0.06% | 79 |
|
|
2023
Q3 | $314K | Hold |
21,823
| – | – | 0.07% | 81 |
|
|
2023
Q2 | $235K | Hold |
21,823
| – | – | 0.05% | 83 |
|
|
2023
Q1 | $183K | Hold |
21,823
| – | – | 0.04% | 85 |
|
|
2022
Q4 | $183K | Hold |
21,823
| – | – | 0.04% | 87 |
|
|
2022
Q3 | $179K | Hold |
21,823
| – | – | 0.04% | 88 |
|
|
2022
Q2 | $177K | Hold |
21,823
| – | – | 0.04% | 87 |
|
|
2022
Q1 | $189K | Hold |
21,823
| – | – | 0.03% | 85 |
|
|
2021
Q4 | $208K | Hold |
21,823
| – | – | 0.03% | 87 |
|
|
2021
Q3 | $367K | Hold |
21,823
| – | – | 0.07% | 84 |
|
|
2021
Q2 | $333K | Hold |
21,823
| – | – | 0.06% | 83 |
|
|
2021
Q1 | $425K | Hold |
21,823
| – | – | 0.09% | 75 |
|
|
2020
Q4 | $393K | Buy |
+21,823
| New | +$393K | 0.09% | 73 |
|